Stay updated on IcoSema vs. Glargine-Aspart in Type 2 Diabetes Clinical Trial

Sign up to get notified when there's something new on the IcoSema vs. Glargine-Aspart in Type 2 Diabetes Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IcoSema vs. Glargine-Aspart in Type 2 Diabetes Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The history now includes additions for Contacts/Locations and Study Status. A deletion on 2024-11-14 removes a prior data item from the record.
    Difference
    0.3%
    Check dated 2025-12-03T13:39:12.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    A new revision entry v3.3.2 has been added to the history, and the previous v3.2.0 entry has been removed.
    Difference
    0.1%
    Check dated 2025-11-26T13:51:19.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Removed the site-wide operating status notice about government funding. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-19T08:32:17.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    Version history indicates multiple entries updating Study Status and Contacts/Locations for NCT05013229, reflecting ongoing status and site information changes.
    Difference
    0.1%
    Check dated 2025-10-28T05:11:44.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Added a government-operation notice and a v3.2.0 revision; removed the v3.1.0 revision. The page now communicates potential service limits due to funding and points to updated status resources, marking a significant update to core content and versioning.
    Difference
    10%
    Check dated 2025-10-06T15:57:07.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    Updated version from v3.0.2 to v3.1.0, indicating a new release. No other content changes were detected.
    Difference
    0.2%
    Check dated 2025-09-29T09:53:44.000Z thumbnail image

Stay in the know with updates to IcoSema vs. Glargine-Aspart in Type 2 Diabetes Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IcoSema vs. Glargine-Aspart in Type 2 Diabetes Clinical Trial page.